161 related articles for article (PubMed ID: 8962211)
1. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
[No Abstract] [Full Text] [Related]
2. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
[No Abstract] [Full Text] [Related]
4. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
Yoshimura N; Ohmori Y; Tsuji T; Oka T
Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
[No Abstract] [Full Text] [Related]
5. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
[No Abstract] [Full Text] [Related]
6. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
[No Abstract] [Full Text] [Related]
7. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
Kandus A; Kovac D; Koselj M; Kveder R; Bren AF
Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824
[No Abstract] [Full Text] [Related]
8. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J
Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779
[No Abstract] [Full Text] [Related]
9. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
[No Abstract] [Full Text] [Related]
10. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
Ghods AJ; Milanian I; Arghani H; Ghadiri G
Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
[No Abstract] [Full Text] [Related]
11. Hyperlipidemia in stable renal transplant recipients.
Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
[No Abstract] [Full Text] [Related]
12. Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
Kandus A; Kovac D; Cerne D; Koselj M; Kaplan-Pavlovcic S; Buturović J; Ponikvar R; Kveder R; Lindic J; Bren AF
Transplant Proc; 1998 Jun; 30(4):1307-9. PubMed ID: 9636530
[No Abstract] [Full Text] [Related]
13. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
Vaessen LM; van Miert PP; van Gelder T; Ijzermans JN; Weimar W
Transplantation; 2001 Apr; 71(8):1175-9. PubMed ID: 11374422
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
16. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
[No Abstract] [Full Text] [Related]
19. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
[No Abstract] [Full Text] [Related]
20. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
